Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Nikken Chemicals prepares PDE4 inhibitors useful for allergic and inflammatory disorders

Oct. 6, 1999

Bayer's IL-4 antagonist for asthma enters clinical testing

Oct. 5, 1999

Zambon and Sheffield initiate MSI albuterol trial for treatment of pediatric asthma

Oct. 4, 1999

Gene Logic and UCB Research enter allergy and asthma gene expression agreement

Oct. 4, 1999

PDL and SB establish asthma therapy collaboration

Oct. 1, 1999

Banyu identifies potent, selective muscarinic M3 antagonist series

Sep. 30, 1999

Anilines from Yamanouchi exert selective inhibition of CRACC

Sep. 27, 1999

Dual PDE4/TNF-alpha inhibitors synthesized and tested at Suntory

Sep. 24, 1999

Intranasal and i.p. administration of anti-IL-5 MAb equieffective in asthmatic mice

Sep. 24, 1999

European researchers describe novel mechanism of action for MPB-07 and MPB-27

Sep. 23, 1999

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...